Latest: Sacheerome Ltd Q1 FY27 results →All Q4 FY26 results →
S

Sacheerome Ltd

Q4 FY26Chemicals & Petrochemicals

Sacheerome Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Price₹475
Market cap₹1.0K Cr
P/E35.8
Updated4 Sept 2026
Read4 min read

What the Q4 FY26 call signalled

2 of 3 strong

RevenueGood growth
MarginMargins steady
CapexCapex planned

The short version

Sacheerome Limited expects gradual revenue growth driven by increasing market demand, customer additions, product mix refinement, and export expansion. Operating margins (EBIT) sustained around 25%-26%, reflecting stable profitability.

From Sacheerome Ltd's Q4 FY26 earnings-call transcript · updated 4 Sept 2026.

Revenue & Sales Performance

Good growth
  • Sacheerome Limited expects gradual revenue growth driven by increasing market demand, customer additions, product mix refinement, and export expansion.
  • The upcoming manufacturing facility at YEIDA, with a significant capacity expansion (approx. 4x increase), is expected to support future growth starting August 2026.
  • Management provided conservative guidance for doubling revenue from around INR152 crores in FY26 to INR300 crores by FY29, emphasizing gradual ramp-up of capacity utilization.
  • There is confidence in demand growth from both domestic FMCG players and global customers, with many products in the development and approval pipeline.
  • They foresee increased market share in both fragrance and flavor segments, with flavors expected to grow rapidly supported by a dedicated facility.

2 more points from Sacheerome Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Sacheerome Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Sacheerome Limited is undertaking a major manufacturing expansion with a new facility at Yamuna Expressway Industrial Development Area (YEIDA).
  • Total capex for this new facility is approximately INR 184 crores.
  • As of March 31, 2026, around INR 76.59 crores have been invested in YEIDA facility—INR 28.79 crores from IPO funds and INR 47.80 crores from internal accruals.
  • The YEIDA facility is expected to commence commercial operations by August 2026.
  • This investment aims to multiply production capacity by 4 times, improve automation, manufacturing efficiency, product consistency, and export capabilities.
  • Additional debt of around INR 60 crores may be taken as required to complete the facility.

2 more points from Sacheerome Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Sacheerome Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The company mentions having a strong demand pipeline with many products in development and commercial launch stages.
  • Manoj Arora highlights that they are operating at overcapacity (around 124% utilization) and expanding capacity to meet growing demand.
  • There is mention of multiple development projects, product approvals, and commercial launches in both fragrances and flavors.
  • The company expects to ramp up production gradually as the new facility (capex INR184 crores) becomes operational.

2 more points from Sacheerome Ltd's call on order book

Create a free account to keep reading this call

Others in Chemicals & Petrochemicals this season

  • Indian Phosphate Ltd (Q4 FY26)

    H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In

  • Paragon Fine (Q4 FY26)

    Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p

  • IVP Ltd (Q4 FY26)

    Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector

  • Vishnu Chemicals Ltd (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Sacheerome Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Sacheerome Ltd Q4 FY26 results?

Sacheerome Limited expects gradual revenue growth driven by increasing market demand, customer additions, product mix refinement, and export expansion. Operating margins (EBIT) sustained around 25%-26%, reflecting stable profitability.

What is Sacheerome Ltd share price analysis?

Sacheerome Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 35.8 with a market cap of ₹1,019 Cr. Investors should review the full earnings analysis for detailed insights.

Is Sacheerome Ltd planning capital expenditure?

Sacheerome Limited is undertaking a major manufacturing expansion with a new facility at Yamuna Expressway Industrial Development Area (YEIDA).

Keep Sacheerome Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.